This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.
Company Profile:
Aldeyra Therapeutics, Inc.
Market Cap (USD):
$304.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Taiwan Liposome Company, Ltd.
Market Cap (USD):
$302.9 M
(Sept. 1, 2021)
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Oyster Point Pharma, Inc.
Market Cap (USD):
$299.9 M
(Dec. 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
iTeos Therapeutics, Inc.
Market Cap (USD):
$292.3 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Hvsen Biotechnology Co. Ltd
Market Cap (USD):
$286.6 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Adimmune Corp
Market Cap (USD):
$285.7 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Atea Pharmaceuticals, Inc.
Market Cap (USD):
$285.1 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Cerecor Inc.
Market Cap (USD):
$285.0 M
(June 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Atrys Health SA
Market Cap (USD):
$282.8 M
Country:
Spain
Sector:
Spanish Healthcare
Industry:
Spanish Biotechnology
Company Profile:
Aquestive Therapeutics, Inc.
Market Cap (USD):
$281.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Y-mAbs Therapeutics, Inc.
Market Cap (USD):
$281.3 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Eledon Pharmaceuticals, Inc.
Market Cap (USD):
$278.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Mycenax Biotech, Inc.
Market Cap (USD):
$275.8 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
C4 Therapeutics, Inc.
Market Cap (USD):
$273.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
CytoDyn, Inc.
Market Cap (USD):
$270.2 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
DiaMedica Therapeutics Inc.
Market Cap (USD):
$269.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Aclaris Therapeutics, Inc.
Market Cap (USD):
$268.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Heron Therapeutics, Inc.
Market Cap (USD):
$267.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
AC Immune SA
Market Cap (USD):
$267.1 M
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
HBM Holdings Ltd
Market Cap (USD):
$266.8 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Immutep Limited
Market Cap (USD):
$266.4 M
(July 1, 2024)
Country:
Australia
Sector:
Australian Healthcare
Industry:
Australian Biotechnology
Company Profile:
Imugene Limited
Market Cap (USD):
$264.1 M
(July 1, 2024)
Country:
Australia
Sector:
Australian Healthcare
Industry:
Australian Biotechnology
Company Profile:
TaiGen Biopharmaceuticals Holdings Ltd
Market Cap (USD):
$263.5 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Verastem, Inc.
Market Cap (USD):
$263.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Amarin Corporation plc
Market Cap (USD):
$257.9 M
Country:
Ireland
Sector:
Irish Healthcare
Industry:
Irish Biotechnology
Company Profile:
Vanda Pharmaceuticals Inc.
Market Cap (USD):
$257.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Chiasma, Inc.
Market Cap (USD):
$253.0 M
(July 1, 2021)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Xspray Pharma AB
Market Cap (USD):
$252.9 M
(July 1, 2024)
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Biotechnology
Company Profile:
Epizyme, Inc.
Market Cap (USD):
$247.5 M
(Aug. 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
BioStem Technologies, Inc.
Market Cap (USD):
$247.3 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology